The Food and Drug Administration has approved a breakthrough cancer medication from Bristol-Myers Squibb Co. that researchers have heralded as the first drug to prolong the lives of patients with melanoma.
FDA clears first melanoma drug to extend life
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.